Cargando…
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
BACKGROUND: Cognitive decline in Alzheimer’s disease (AD) is associated with hyperphosphorylated tau (pTau) propagation between neurons along synaptically connected networks, in part via extracellular vesicles (EVs). EV biogenesis is triggered by ceramide enrichment at the plasma membrane from neutr...
Autores principales: | Tallon, Carolyn, Bell, Benjamin J., Malvankar, Medhinee M., Deme, Pragney, Nogueras-Ortiz, Carlos, Eren, Erden, Thomas, Ajit G., Hollinger, Kristen R., Pal, Arindom, Mustapic, Maja, Huang, Meixiang, Coleman, Kaleem, Joe, Tawnjerae R., Rais, Rana, Haughey, Norman J., Kapogiannis, Dimitrios, Slusher, Barbara S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694940/ https://www.ncbi.nlm.nih.gov/pubmed/38049923 http://dx.doi.org/10.1186/s40035-023-00383-9 |
Ejemplares similares
-
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer’s disease
por: Tallon, Carolyn, et al.
Publicado: (2023) -
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
por: Tallon, Carolyn, et al.
Publicado: (2022) -
Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
por: Huang, Meixiang, et al.
Publicado: (2023) -
Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling
por: Yabu, T, et al.
Publicado: (2015) -
Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi
por: Gu, LiZe, et al.
Publicado: (2013)